Research suggests that genetic sequencing technologies should be used to screen for mutated cells in stem cell cultures, so they can be excluded from scientific experiments and clinical therapies.
Researchers at the Institute for Aging Research, which operates within Hebrew Senior Life, the only senior health care and housing organization affiliated with Harvard Medical School, have studied how to prevent falls, a leading cause of preventable death among older adults.
Scientists studying stem cell and regenerative biology are probing the secrets of aging, examining both whether decline is inevitable and how to fight the diseases that multiply with time.
For nearly 80 years, the Harvard Study of Adult Development has been producing data and lessons on how to live longer, happier, and healthier lives.
The body’s ability to repair DNA damage declines with age, which causes gradual cell demise, overall bodily degeneration, and greater susceptibility to cancer. Experiments in mice suggest a way to thwart DNA damage.
On Match Day 2017, more than 150 Harvard Medical School students learned where they will spend the next three to seven years of their training.
A new study led by Harvard Medical School and Harvard T.H. Chan School of Public Health researchers examines the impact of individual physicians’ spending patterns on patient outcomes.
The Wyss Institute and Harvard Medical School’s Personal Genome Project are collaborating with Lumos Labs, the makers of Lumosity, to investigate the relationship between genetics and memory, attention, and reaction speed.
Psychiatrist Jeff Huff is leading an MGH effort to determine whether positive thinking can promote better health.
Researchers find vitamin D helps the body fight acute respiratory infection.
A study by Harvard Medical School faculty members at Brigham and Women’s Hospital is exploring the health benefits of cocoa in a massive, 18,000-person study that may provide answers hinted at in smaller studies.
The Gazette speaks with the Medical School's Staci Gruber, who thinks that state marijuana legalization policy has run ahead of science.
A Wintersession course studied compassion and suffering through the lenses of dance, music, and science.
Harvard Medical School scientists and colleagues from Massachusetts General Hospital have partly restored hearing in mice with a genetic form of deafness. The new approach overcomes a longstanding barrier to gene therapy for inherited and acquired deafness.
A new study out of Harvard-affiliated Dana-Farber/Boston Children’s Cancer and Blood Disorders Center suggests that precision medicine can provide vital care in treatment and diagnosis of pediatric brain tumors.
A new study by researchers at Beth Israel Deaconess Medical Center examines the neuroanatomy behind delusional misidentification syndromes.
Harvard Medical School geneticist Stephen Elledge won the 2017 Breakthrough Prize for unraveling the mechanism by which cells sense DNA damage and initiate self-repair.
Physicians share how music shapes their lives and impacts their practice when working with patients and even in the operating room.
The future of visual and augmented reality was the theme of a HUBweek event that attracted students, scientists, educators, entrepreneurs, and software developers for an afternoon of demonstrations and discussions.
A gene therapy trial points to a healthier future for a young patient suffering from a rare immune disease.
Harvard Medical School Professor William G. Kaelin Jr. was named the winner of the 2016 Lasker Award for Medical Research, America’s most prestigious biomedical award. He was honored for his work in the root causes of cancer.
Scientists at Harvard Medical School and Technion-Israel Institute of Technology have built a giant petri dish to visually demonstrate how bacteria move as they become immune to drugs.
Harvard researchers have riddled the role of a molecule key to eruption of the torturous blisters as well as an antibody that interrupts the inflammatory response, opening the way to potential relief for careless hikers.
Two recent studies have shown that cells early in development can be marked with a genetic barcode that later can be used to reconstruct their lineage.
George Q. Daley will become the next dean of the Faculty of Medicine at Harvard Medical School, Harvard President Drew Faust and Provost Alan Garber announced.
With a super-resolution microscopy, a team of researchers at Harvard’s Wyss Institute has leveraged the power of programmable DNA.
Barbara McNeil, health policy expert and longtime faculty member, to serve as interim dean at Harvard Medical School.
The Gazette spoke with psychologist Richard Mollica about a lesser known crisis zone for the displaced: mental health.
The Radcliffe Institute for Advanced Study has named 50 fellows for the 2016-17 academic year. Eleven of the incoming class are Harvard faculty.
Five Harvard faculty members were elected to the National Academy of Arts and Sciences.
In myriad ways, Harvard is working across its campus to reduce energy use, curb climate change.
The American Academy of Arts and Sciences today announced the election of 213 new members. They include several Harvard faculty members. The new class will be inducted at a ceremony on Oct. 8 in Cambridge, Mass.
Shifts in the medical care field can allow health care providers both to prosper and to serve patients better, speaker tells Harvard Medical School conference.
Levels of a molecular marker in healthy breast tissue can predict a woman’s risk of getting cancer, according to new research from the Harvard Stem Cell Institute.
Husband and wife Eric Minikel and Sonia Vallabh have found a home at the Broad Institute to work toward a treatment for her fatal disease.
Harvard offers myriad programs to alleviate the inequality gap within the University, from neighboring communities to overseas.
"Standardized patients" are trained actors who role-play the sort of diagnostic puzzles regularly faced by practicing physicians. They interact with students at the Tosteson Medical Education Center at Harvard Medical School (HMS).
In recent decades, women have made progress in pay and parity with men in such professions as medicine and law. But when it comes to running things at the highest levels, it’s generally still a man’s world.
An analysis of data from two long-term epidemiologic studies has found that regular use of aspirin significantly reduces the overall risk of cancer, an effect that primarily reflects a lower risk of colorectal cancer and other tumors of the gastrointestinal tract.
National health insurance is just a first step to solving the divide between America’s well-off healthy and its poorer, sicker people, Harvard analysts say.
Cameron Waites served in Iraq as an Army medic/health care specialist from 2004 to 2008. At 34, he is a student at Harvard Medical School where he hopes to discover solutions to problems that plague his fellow veterans.
The Gazette spoke with Michael Charness, chief of staff for the Harvard-affiliated VA Boston Healthcare System, about the CDC’s recommendations to sexually active woman of childbearing age: either use birth control or don’t drink.
A team of researchers from the Wyss Institute and Harvard Medical School has developed a new method for engineering a broad range of biosensors to detect and signal virtually any desired molecule using living eukaryotic cells. Its applications could range from detecting hormones to benefiting agriculture.
In a new study, the Wyss Institute’s human-gut-on-a-chip technology is used to co-culture gut microbiome and human intestinal cells, which could spur innovation of novel therapies for inflammatory bowel diseases.
Three Harvard professors and scientists have been named fellows of the National Academy of Inventors.
Harvard psychiatrist Ronald Schouten answers questions on the San Bernardino attack and the psychology behind both terrorism and the fear it spreads.
During an Ed Portal discussion, Harvard Professor Ashish Jha examined where the global health system failed when Ebola began to spread.
Jeffrey S. Flier will step down as dean of Harvard Medical School next July and return to teaching following a sabbatical year in 2016-17.
Harvard addiction specialist on FDA’s OxyContin OK: We have to respond to both patients and population health, a tricky task.
The first study to measure the incidence of medication errors and adverse drug events during the perioperative period has found that some sort of mistake or adverse event occurred in every second operation and in 5 percent of observed drug administrations, according to information gathered from 275 operations at Massachusetts General Hospital.